Cytoscient provides preclinical DMPK, bioanalytical service for both small molecule and biologics.

Cytoscient offers expert services for pharmaceutical and biomarker development. Our goal is to provide high quality data that is cost-effective and rapid for your decision making.

Our extensive experience includes early drug discovery, IND-enabling toxicology, and clinical trials. We know how to characterize new drug candidates, and to confidently translate results at each development stage.